OneStopGate.Com
OnestopGate   OnestopGate
   Sunday, September 21, 2014 Login  
OnestopGate
Home | Overview | Syllabus | Tutorials | FAQs | Downloads | Recommended Websites | Advertise | Payments | Contact Us | Forum
OneStopGate

GATE Resources
Gate Articles
Gate Books
Gate Colleges 
Gate Downloads 
Gate Faqs
Gate Jobs
Gate News 
Gate Sample Papers
Training Institutes

GATE Overview
Overview
GATE Eligibility
Structure Of GATE
GATE Coaching Centers
Colleges Providing M.Tech/M.E.
GATE Score
GATE Results
PG with Scholarships
Article On GATE
Admission Process For M.Tech/ MCP-PhD
GATE Topper 2012-13
GATE Forum




GATE 2015 Exclusive
Organizing Institute
Important Dates
How to Apply
Discipline Codes
GATE 2015 Exam Structure

GATE 2015 Syllabus
Aerospace Engg..
Agricultural Engg..
Architecture and Planning
Chemical Engg..
Chemistry
Civil Engg..
Computer Science / IT
Electronics & Communication Engg..
Electrical Engg..
Engineering Sciences
Geology and Geophysics
Instrumentation Engineering
Life Sciences
Mathematics
Mechanical Engg..
Metallurgical Engg..
Mining Engg..
Physics
Production & Industrial Engg..
Pharmaceutical Sciences
Textile Engineering and Fibre Science

GATE Study Material
Aerospace Engg..
Agricultural Engg..
Chemical Engg..
Chemistry
Civil Engg..
Computer Science / IT
Electronics & Communication Engg..
Electrical Engg..
Engineering Sciences
Instrumentation Engg..
Life Sciences
Mathematics
Mechanical Engg..
Physics
Pharmaceutical Sciences
Textile Engineering  and Fibre Science

GATE Preparation
GATE Pattern
GATE Tips N Tricks
Compare Evaluation
Sample Papers 
Gate Downloads 
Experts View

CEED 2013
CEED Exams
Eligibility
Application Forms
Important Dates
Contact Address
Examination Centres
CEED Sample Papers

Discuss GATE
GATE Forum
Exam Cities
Contact Details
Bank Details

Miscellaneous
Advertisment
Contact Us


Home » GATE Study Material » Pharmaceutical Science » Medicinal Chemistry » Antiamoebic drugs


Antiamoebic drugs


Looking for GATE Preparation Material? Join & Get here now!

** Gate 2013 Question Papers.. ** CEED 2013 Results.. ** Gate 2013 Question Papers With Solutions.. ** GATE 2013 CUT-OFFs.. ** GATE 2013 Results.. **

Antiamoebic drugs

Antiamoebic drugs


Abstract


Background

Amoebiasis is a major public health problem in tropical and subtropical countries. Although a number of antiamoebic agents are used for its treatment, yet the susceptibility data on clinical isolates of Entamoeba histolytica and Entamoeba dispar are not available. Therefore, the present study was aimed to assess the in vitro susceptibility of clinical isolates of E. histolytica and E. dispar to metronidazole, chloroquine, emetine and tinidazole.



Methods

A total of 45 clinical isolates (15 E. histolytica and 30 E. dispar) were maintained in polyxenic cultures followed by monoxenic cultures. In vitro drug sensitivity (IC50) of clinical isolates and standard reference strain of E. histolytica (HM1: IMSS) was assessed by nitro blue tetrazolium (NBT) reduction assay after exposure to various concentrations of each drug.

Results

The results showed that all clinical isolates had a higher IC50 compared to reference strain to all the four drugs. E. histolytica isolates appeared to be more susceptible [IC50 (hormone-μm) 13.2,26.3,31.2 and 12.4] compared to E. dispar isolates [IC50(hormone-μm) 15.6,28.9,32.8 and 13.2] and the reference strain of E. histolytica [IC50 (hormone-μm) 9.5, 15.5, 29.9 and 10.2] to the metronidazole, chloroquine, emetine and tinidazole respectively.

Conclusions

The results indicate that till date, Entamoeba isolates in India do not seem to be resistant to the commonly used Antiamoebic drugs.


Background

Entamoeba histolytica, is the etiological agent of amoebic dysentery and amoebic liver abscess (ALA). Worldwide, 40-50 million symptomatic cases of amoebiasis occur annually and 70,000 to 100,000 deaths due to this infection . There are two distinct, but morphologically identical species of Entamoeba: Entamoeba histolytica, which is pathogenic and Entamoeba dispar, which is non-pathogenic. E. histolytica, has the capacity to invade intestinal mucosa resulting in intestinal amoebiasis and cause extra intestinal amoebiasis [amoebic liver abscess (ALA)] .

Infection is primarily treated by instituting antiamoebic therapy. Drugs of choice for invasive amoebiasis are tissue active agents, like metronidazole, tinidazole and chloroquine or the more toxic emetine derivatives, including dehydroemetine. Metronidazole and tinidazole are derived from 5-nitroimdazole which kill the trophozoites by alterations in the protoplasmic organelles of the amoeba, but are ineffective in the treatment of cyst passers. Chloroquine is derived from 4-aminoquinolines, which acts on the vegetative forms of the parasite and kills it by inhibiting DNA synthesis. Emetine, a plant alkaloid, kills the trophozoites of E. histolytica mainly by inhibiting protein synthesis.

Indiscriminate use of drugs has led to an increase in the minimum inhibitory concentration (MIC) of these therapeutic agents . Although, drug resistance to E. histolytica does not appear to be a serious problem, there are occasional reports of failure with metronidazole suggesting that this could probably be heralding the development of drug resistance clinically . Recurrence of ALA even after treatment with metronidazole has been reported and parasites may survive in spite of adequate treatment . However, differences in drug sensitivity between strains of E. histolytica have been reported, indicating that there may be a small percentage of amoebae which are either resistant to the drug or may even eventually become resistant due to abuse of antiamoebic agents . Although, earlier studies have been focused on in vitro sensitivity of the only axenic strains of E. histolytica , yet to the best of our knowledge, studies on in vitro drug susceptibility studies on clinical isolates of E. histolytica and E. dispar have not been reported. Therefore, in the present study an attempt has been made to assess the in vitro activity of Antiamoebic drugs (emetine, chloroquine, metronidazole and tinidazole) against clinical isolates of E. histolytica and E. dispar.


Methods


Clinical isolates

Forty-five isolates from patients attending the Out Patient Departments of Nehru hospital, attached to the Post Graduate Institute of Medical Education & Research, Chandigarh, India, identified earlier as either E. histolytica (15) or E. dispar (30) by hexokinase isoenzyme analysis and by Techlab ELISA were used in the present study. These have been cultured in modified Boeck and Drbohlav (NIH) medium followed by Robinson's medium .

Preparation of antimicrobial agents

The drugs (metronidazole, chloroquine, emetine dihydrochloride and tinidazole) used in the study were procured as pure salt from Sigma-Aldrich Co., St. Louis, MO., 63178 USA. The stock solutions of drugs (each 0.1 M) were prepared in dimethyl sulphoxide (DMSO) and stored at -20C till use. The stock solutions were diluted in medium to the required concentration. A starting concentration used was 200 hormone-μM, which yielded a maximum concentration in the assay of 17.1 hormone-μg/ml metronidazole, 51.59 hormone-μg/ml chloroquine, 55.3 hormone-μg/ml emetine, and 24.7 hormone-μg/ml tinidazole.

In vitro drug sensitivity assay

Drug sensitivity to all the compounds was carried out by nitroblue tetrazolium (NBT) reduction method . Each clinical isolate was tested in duplicate along with the reference E. histolytica strain (HM1: IMSS). Amoebae were harvested from 24 hour old cultures and suspended in medium. The parasite count was adjusted to 3 105 parasites/ml in medium by haemocytometer .

The assay was carried out in microtiter plates (Grenier bio-one, Germany). Briefly, in row A 200 hormone-μl of drug and in all other rows (B-H) medium was added and doubling dilutions of the drug were performed down the plate. Final drug concentration in rows A-H was as follows: 100, 50, 25, 12.5, 6.25, 3.12, 1.6 and 0.8 (hormone-μM). Further 100 hormone-μl of parasite suspension (3 105/well) was added to all the rows (A-H). Each test included control (without drug) and blank wells (medium only). The plates were incubated at 37C for 4 hrs. The contents of the plates were discarded and washed with pre warmed Hank's balanced salt solution (HBSS pH 7.2). Thereafter, 100 hormone-μl of NBT/well in HBSS was added and the plates were incubated at 37C for 45 min. followed by aspiration of the contents. Plates were then washed with HBSS twice and 200 hormone-μl/well of DMSO (100% v/v) was added. Following incubation at 37C for 10 min, the optical density (OD) was measured in an ELISA recorder at 540 nm.

The percentage of non-viable organisms, which failed to metabolize NBT and therefore did not produce the dark blue formazan product, was determined by applying the following formula:

Percentage of non-viable organisms at each drug conc. =

Statistical analysis

The mean IC50 values of all clinical isolates against the four drugs were compared with corresponding IC50 values of the reference E. histolytica strain (HM1: IMSS). Standard deviation (SD) was used to indicate the extent of variation around group mean values. The p value was calculated using the student's-t test.


Results


The IC50 values of emetine, chloroquine, metronidazole and tinidazole for the 45 clinical isolates [15 E. histolytica and 30 E. dispar] and the reference strain HM1: IMSS were determined by the NBT reduction assay. The mean IC50 values were significantly higher (P < 0.001) in E. dispar isolates to all the four Antiamoebic drugs as compared to the E. histolytica isolates and the reference E. histolytica strain  


Discussion


Treatment failure among amoebiasis patients often raises the possibility of drug resistance . In the present study the 15 E. histolytica and 30 E. dispar clinical isolates maintained by in vitro cultivation in monoxenic medium were subjected to drug susceptibility tests against four Antiamoebic drugs: metronidazole, chloroquine, emetine and tinidazole by NBT reduction assay. E. histolytica reference strain (HM1: IMSS) was also included in each set of experiments.

Results showed a significant difference in drug sensitivity in clinical isolates as compared to the reference strain with all the four drugs. The mean IC50 values (hormone-μm) of the E. histolytica/E. dispar isolates against metronidazole, chloroquine, emetine and tinidazole were 13.2/15.6, 26.3/28.9, 31.2/32.8 and 12.4/13.2 respectively. The IC50 values (hormone-μm) of the reference strain against all the four respective drugs were 9.5, 15.5, 29.9 and 10.2. Recently Upcroft & Upcroft have reported that the MIC values of metronidazole ranges from 12.5-25 hormone-μm for laboratory-passaged E. histolytica strains. Adagu, et.al. have shown the mean metronidazole IC50 value as 18.47 hormone-μm for the most susceptible isolates of E. histolytica with a > 30 hormone-μm value as the cut off for resistance. Burchard & Mirelman, studied in vitro sensitivity to metronidazole and emetine of non-pathogenic zymodemes and showed that all were similarly sensitive to both the drugs (1-10 hormone-μg/ml) . In the present study, clinical isolates maintained in monoxenic culture were used to detect the in vitro sensitivity as earlier it has been concluded that bacterial flora associated with the amebae did not significantly interfere with the test performance and sensitivity values .

Although resistance to metronidazole has been reported against Trichomonas vaginalis , Giardia lamblia and Leishmania donovani , yet to the best of our knowledge there is no documented resistance among clinical isolates of E. histolytica and E. dispar.


Conclusion


The results of the present study are in agreement with previous findings , except that there was a significantly higher IC50 value of all four drugs to the clinical isolates as compared to the reference strain. E. dispar isolates showed higher IC50 values when compared to E. histolytica or reference strain. This is the first report of in vitro drug sensitivity pattern to clinical isolates of E. histolytica and E. dispar. There is definitely a need to monitor the random drug susceptibility among clinical isolates especially in context to widespread use of metronidazole and tinidazole, which are available over the counter in many countries. Increased awareness and continued surveillance for the possible emergence of resistance among clinical isolates is necessary for the ultimate prevention and control of amoebiasis.



Discussion Center

Discuss/
Query

Papers/
Syllabus

Feedback/
Suggestion

Yahoo
Groups

Sirfdosti
Groups

Contact
Us

MEMBERS LOGIN
  
Email ID:
Password:

  Forgot Password?
 New User? Register!

INTERVIEW EBOOK
Get 9,000+ Interview Questions & Answers in an eBook. Interview Question & Answer Guide
  • 9,000+ Interview Questions
  • All Questions Answered
  • 5 FREE Bonuses
  • Free Upgrades
GATE RESOURCES
 
  • Gate Books
  • Training Institutes
  • Gate FAQs
  • GATE BOOKS
     
  • Mechanical Engineeering Books
  • Robotics Automations Engineering Books
  • Civil Engineering Books
  • Chemical Engineering Books
  • Environmental Engineering Books
  • Electrical Engineering Books
  • Electronics Engineering Books
  • Information Technology Books
  • Software Engineering Books
  • GATE Preparation Books
  • Exciting Offers



    GATE Exam, Gate 2009, Gate Papers, Gate Preparation & Related Pages


    GATE Overview | GATE Eligibility | Structure Of GATE | GATE Training Institutes | Colleges Providing M.Tech/M.E. | GATE Score | GATE Results | PG with Scholarships | Article On GATE | GATE Forum | GATE 2009 Exclusive | GATE 2009 Syllabus | GATE Organizing Institute | Important Dates for GATE Exam | How to Apply for GATE | Discipline / Branch Codes | GATE Syllabus for Aerospace Engineering | GATE Syllabus for Agricultural Engineering | GATE Syllabus for Architecture and Planning | GATE Syllabus for Chemical Engineering | GATE Syllabus for Chemistry | GATE Syllabus for Civil Engineering | GATE Syllabus for Computer Science / IT | GATE Syllabus for Electronics and Communication Engineering | GATE Syllabus for Engineering Sciences | GATE Syllabus for Geology and Geophysics | GATE Syllabus for Instrumentation Engineering | GATE Syllabus for Life Sciences | GATE Syllabus for Mathematics | GATE Syllabus for Mechanical Engineering | GATE Syllabus for Metallurgical Engineering | GATE Syllabus for Mining Engineering | GATE Syllabus for Physics | GATE Syllabus for Production and Industrial Engineering | GATE Syllabus for Pharmaceutical Sciences | GATE Syllabus for Textile Engineering and Fibre Science | GATE Preparation | GATE Pattern | GATE Tips & Tricks | GATE Compare Evaluation | GATE Sample Papers | GATE Downloads | Experts View on GATE | CEED 2009 | CEED 2009 Exam | Eligibility for CEED Exam | Application forms of CEED Exam | Important Dates of CEED Exam | Contact Address for CEED Exam | CEED Examination Centres | CEED Sample Papers | Discuss GATE | GATE Forum of OneStopGATE.com | GATE Exam Cities | Contact Details for GATE | Bank Details for GATE | GATE Miscellaneous Info | GATE FAQs | Advertisement on GATE | Contact Us on OneStopGATE |
    Copyright © 2014. One Stop Gate.com. All rights reserved Testimonials |Link To Us |Sitemap |Privacy Policy | Terms and Conditions|About Us
    Our Portals : Academic Tutorials | Best eBooksworld | Beyond Stats | City Details | Interview Questions | India Job Forum | Excellent Mobiles | Free Bangalore | Give Me The Code | Gog Logo | Free Classifieds | Jobs Assist | Interview Questions | One Stop FAQs | One Stop GATE | One Stop GRE | One Stop IAS | One Stop MBA | One Stop SAP | One Stop Testing | Web Hosting | Quick Site Kit | Sirf Dosti | Source Codes World | Tasty Food | Tech Archive | Software Testing Interview Questions | Free Online Exams | The Galz | Top Masala | Vyom | Vyom eBooks | Vyom International | Vyom Links | Vyoms | Vyom World
    C Interview Questions | C++ Interview Questions | Send Free SMS | Placement Papers | SMS Jokes | Cool Forwards | Romantic Shayari